High expression of Notch receptors (Notch 1 and 4) and components like HES-related protein (Hey1) and Delta-like ligand (DII1) are associated with worse GBM outcomes, such as reduced survival and higher tumor grades 51,52. The gene discussed is NOTCH1; the disease is glioblastoma.